Showing results (171-180 of 360) with videos related to
Sort By:
Pageof 36
European Urology Oncology|March 12, 2024
A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal DisparitiesOlivier Cussenot, Yoann Taille, Jean-Jacques Portal, et al.The Prostate|March 30, 2011
Biomarkers for the diagnosis of prostatic inflammation in benign prostatic hyperplasiaGrégoire Robert, Frank Smit, Daphne Hessels, et al.World Journal of Urology|November 8, 2006
Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimenAurélien Descazeaud, Mark Rubin, Stéphanie Chemama, et al.Frontiers in Oncology|May 19, 2023
Surgical and oncological management of renal medullary carcinoma in a young patient: a case reportJean Courcier, Alexandre De La Taille, Riccardo Bertolo, et al.European Urology|January 1, 2003
Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factorsLaurent Salomon, Olivier Levrel, Aristotelis G Anastasiadis, et al.Cancers|December 11, 2022
Correction: Diamant et al. Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer. <i>Cancers</i> 2022, <i>14</i>, 3797Elliott Diamant, Mathieu Roumiguié, Alexandre Ingels, et al.Journal of Robotic Surgery|September 4, 2024
Impact of robotic-assisted surgery on length of hospital stay in Paris public hospitals: a retrospective analysisThomas Blanc, Carmen Capito, Edward Lambert, et al.World Journal of Urology|June 26, 2010
Impact of oral anticoagulation on morbidity of transurethral resection of the prostateAurélien Descazeaud, Gregoire Robert, Souhil Lebdai, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 14, 2008
Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa)Frank Giton, Alexandre de la Taille, Yves Allory, et al.Neoplasia (New York, N.Y.)|July 2, 2013
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancerStéphane Terry, Pascale Maillé, Habiba Baaddi, et al.Pageof 36